Antiviral agents Tenofovir for prevention of emerging HIV infections among MSM population: an open, randomized, multi center, paralleled controlled trial
Phase of Trial: Phase IV
Latest Information Update: 04 Jul 2016
Price : $35 *
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 31 May 2016 Status changed from active, no longer recruiting to completed.
- 31 May 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 27 Nov 2013 New trial record